Sequelae in adults at six months after COVID-19 infection | All the latest medical news on the portal Medznat.ru. :- Medznat
EN | RU
EN | RU

Help Support

By clicking the "Submit" button, you accept the terms of the User Agreement, including those related to the processing of your personal data. More about data processing in the Policy.
Back

Sequelae in adults at six months after COVID-19 infection

Sequelae in adults at six months after COVID-19 infection Sequelae in adults at six months after COVID-19 infection
Sequelae in adults at six months after COVID-19 infection Sequelae in adults at six months after COVID-19 infection

What's new?

The health consequences of the coronavirus disease 2019 (COVID-19) were found to extend far beyond acute infection, even among patients reporting mild illness.

As per the study published in “JAMA Network Open” on 19 Februrary 2021 indicated that the health consequences of the deadly coronavirus extend far beyond acute infection, even in patients witnessing mild illness. This longitudinal prospective cohort study conducted by Jennifer K. Logue et al. presents the longest follow-up symptom evaluation after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

The study included subjects with laboratory-confirmed coronavirus infection. A concurrent cohort of healthy individuals was included in the control arm. The coronavirus symptom data were procured at the time of acute illness or retrospectively recounted at a 30-day recruitment visit. Notably, COVID-19 subjects (n=234) were requested to complete a follow-up questionnaire between third and ninth months.

Overall, 75.6% (177/234) of participants infected with coronavirus completed the survey. In total, 6.2% (n=11) were asymptomatic, 84.7% (n=150) subjects had mild illness, and 9% (n=16) had moderate or severe disease needing hospitalization. Hypertension was witnessed to be the most frequently occurring comorbidity (13%, n=23). The follow-up survey was completed a median of 169 days after infection onset by coronavirus-infected subjects and 87 days after recruitment by 21 subjects in the control arm.

Among coronavirus-infected subjects, persistent symptoms were reported by 26.6% (17/64) subjects (age 18-39 years), 30.1% (25/83) subjects (age 40-64 years), and 43.3% (13/30) subjects (age 65 years and older). It was noted that 32.7% (49/150) outpatients, 31.3% (5/16) hospitalized patients, and 4.8% (1/21) healthy participants in the control arm witnessed at least one persistent symptom. Of 31 subjects having diabetes or hypertension, 35.5% (n=11) witnessed ongoing symptoms. The most frequently noted persistent symptoms were fatigue (13.6% [24/177] subjects) and loss of sense of taste or smell (13.6% [24/177] subjects).

In total, 23 subjects (13%) witnessed other symptoms, including brain fog (2.3%, n=4). In this study, 51 outpatients and hospitalized individuals (30.7%) were found to report deteriorating health-related quality of life in comparison with baseline vs. four healthy participants and asymptomatic subjects (12.5%). Notably, 14 subjects (7.9%) witnessed negative effects on at least one activity of daily living, the household chores were found to be the most prevalent. Comprehensive long-term research will be required to completely elucidate the impact of this evolving viral pathogen, concluded the study authors. The study results suggest that COVID-19 does not just prompt mild illness, but its outcomes are beyond acute illness.

Source:

JAMA Network Open

Article:

Sequelae in Adults at 6 Months After COVID-19 Infection

Authors:

Jennifer K. Logue et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru ua
Try: